Blue Light Cystoscopy With Cysview® Registry
ConditionBladder Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPhotocure
About this trial
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
Eligibility criteria
Qualifiers
Adult >18 years old
Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy
Disqualifiers
Porphyria
Gross hematuria
Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives
Trial design
Treatments tested in this trial
- Hexaminolevulinate hydrochloride (HCL)
- Karl Storz D-Light C Photodynamic Diagnostic (PDD) system
Treatment groups
4,400 Participants
are divided into 1 treatment groupSponsors and collaborators
Photocure
Lead sponsor
Catalyst Pharmaceutical Research
Collaborator
Source ClinicalTrials.gov